ONC Q3 2019 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q3 2019 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$50M-7.5% YoY

Gross Profit

-$207M-412.7% margin

Operating Income

-$312M-622.8% margin

Net Income

-$307M-613.0% margin

EPS (Diluted)

$-5.07

QoQ Revenue Growth

-79.4%

Cash Flow

Operating Cash Flow

-$265M

Free Cash Flow

-$296M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$587M

Stockholders' Equity

$1.3B

Cash & Equivalents

$856M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$54M	-7.5%
Gross Profit	-$207M	-$102M	-102.7%
Operating Income	-$312M	-$151M	-106.7%
Net Income	-$307M	-$144M	-113.4%